A weight loss pill that works like Ozempic? Early data on orforglipron sparks major buzz |
Interest in therapies that support weight management has grown rapidly as new metabolic medicines reshape treatment choices and public expectations. Orforglipron, an oral GLP-1 receptor agonist, has become a key focus because it offers a tablet-based alternative to injectable options such as semaglutide and tirzepatide. Many individuals prefer oral medication for daily use, particularly when…